PM
TBIO

Penbrook Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Penbrook Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,685
Closed -$141K – 106
2023
Q4 		$141K Sell
19,685
-513
-3% -$5.7K 0.1% 98
2023
Q3 		$378K Sell
20,198
-11
-0.1% -$268 0.28% 73
2023
Q2 		$575K Buy
20,209
+1,183
+6% +$47.2K 0.42% 54
2023
Q1 		$1.06M Buy
19,026
+4,090
+27% +$145K 0.81% 31
2022
Q4 		$323K Hold
14,936
– – 0.28% 74
2022
Q3 		$446K Buy
14,936
+4,587
+44% +$161K 0.38% 64
2022
Q2 		$335K Buy
10,349
+2,340
+29% +$162K 0.26% 81
2022
Q1 		$774K Buy
+8,009
New +$1.21M 0.5% 59

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return